All companies
Visit website
WAXELENE
OperatingWaxelene, Inc.
Retail · Founded 2011
Future of organic skin care
Valuation cap ⓘ
$8.0M
As of Apr 2024 · from WAXELENE Future Equity SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$56,341
Across 1 round since 2023
Latest share price
$1.00
WAXELENE Future Equity SAFE 1 offering price
Financials
FY2021–FY2022 · from SEC filings · hover any figure for its source$603K
$15K
2021
$844K
−$2K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
Income statement
Revenue
$602,929
$843,812
Cost of goods sold
$359,088
$397,071
Gross margin
40%
53%
Net income
$14,982
-$1,900
Taxes paid
$0
$0
Balance sheet
Cash
$46,481
$81,546
Accounts receivable
$0
$0
Total assets
$77,666
$111,862
Short-term debt
$60,789
$159,042
Long-term debt
$268,268
$197,447
Total liabilities
$329,057
$356,489
Other
Headcount
—
1
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$8.0M
Valuation cap
WAXELENE Future Equity SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $56.3K / $1.2MInvestors 59Valuation cap $8M
Reg CF annual-report compliance
Delinquent
Filed 0 of 3 annual reports (FY2023–FY2025)
Missing: 2023, 2024, 2025
59 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001543717Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.